Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
AssigneeYale University
InventorsDavid Spiegel, Christopher Parker
Life of this patent
Estimating the term…
Loading patent…
AssigneeYale University
InventorsDavid Spiegel, Christopher Parker
Estimating the term…
The present invention is directed to new bifunctional compounds and methods for treating HIV infections. The bifunctional small molecules, generally referred to as ARM-HI's, function through orthogonal pathways, by inhibiting the gp120-CD4 interaction, and by recruiting anti-DNP antibodies to gp120-expressing cells, thereby preventing cell infection and spread of HIV. It has been shown that ARM-HI's bind to gp120 and gp-120 expressing cells competitively with CD4, thereby decreasing viral infectivity as shown by an MT-2 cell assay, the binding leading to formation of a ternary complex by recruiting anti-DNP antibodies to bind thereto, the antibodies present in the ternary complex promoting the complement-dependent destruction of the gp120-expressing cells. Compounds and methods are described herein.
A method of synthesizing a compound according to the chemical structure 16:
A compound according to the chemical structure:
Dependencies are inferred from the claim text.